BIOADAPTIVES, INC. (BDPT)
About BIOADAPTIVES, INC.
BIOADAPTIVES INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $18.3K
- Net income
- -$1.6M
- Total assets
- $225.9K
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Bioadaptives, Inc. (BDPT) Stock Price
- Reported a net loss of $1.6M in FY2025.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BIOADAPTIVES, INC..
Write a review
News about BIOADAPTIVES, INC.
News & sentiment via Polygon.io
Bioadaptives, Inc.: frequently asked questions
Is Bioadaptives, Inc. an American company?
Bioadaptives, Inc. is a US-based company headquartered in Las Vegas, Nevada, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Bioadaptives, Inc. headquartered?
Bioadaptives, Inc. is headquartered in Las Vegas, Nevada, United States.
Is Bioadaptives, Inc. publicly traded?
Yes — Bioadaptives, Inc. is a publicly traded company. Its stock trades under the ticker symbol BDPT on the OTC.
What does Bioadaptives, Inc. do?
Bioadaptives, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
